Last reviewed · How we verify
Dexamethasone 8 mg
Dexamethasone 8 mg is a Small molecule drug developed by Indonesia University. It is currently FDA-approved. Also known as: 0.9 % sodium chloride, 12.5 mg of 0.125% bupivacaine, Dexamethasone 4 mg/ml.
At a glance
| Generic name | Dexamethasone 8 mg |
|---|---|
| Also known as | 0.9 % sodium chloride, 12.5 mg of 0.125% bupivacaine, Dexamethasone 4 mg/ml |
| Sponsor | Indonesia University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Improving White Blood Cell Collection From Healthy Donors (PHASE4)
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) (PHASE3)
- Dose Dependent Steroid Injections (PHASE4)
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) (PHASE3)
- Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (PHASE2)
- Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma (PHASE1)
- Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre (NA)
- Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexamethasone 8 mg CI brief — competitive landscape report
- Dexamethasone 8 mg updates RSS · CI watch RSS
- Indonesia University portfolio CI
Frequently asked questions about Dexamethasone 8 mg
What is Dexamethasone 8 mg?
Dexamethasone 8 mg is a Small molecule drug developed by Indonesia University.
Who makes Dexamethasone 8 mg?
Dexamethasone 8 mg is developed and marketed by Indonesia University (see full Indonesia University pipeline at /company/indonesia-university).
Is Dexamethasone 8 mg also known as anything else?
Dexamethasone 8 mg is also known as 0.9 % sodium chloride, 12.5 mg of 0.125% bupivacaine, Dexamethasone 4 mg/ml.
What development phase is Dexamethasone 8 mg in?
Dexamethasone 8 mg is FDA-approved (marketed).
Related
- Manufacturer: Indonesia University — full pipeline
- Also known as: 0.9 % sodium chloride, 12.5 mg of 0.125% bupivacaine, Dexamethasone 4 mg/ml
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing